Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TL-895 by Telios Pharma for Systemic Mastocytosis: Likelihood of Approval
TL-895 is under clinical development by Telios Pharma and currently in Phase II for Systemic Mastocytosis. According to GlobalData, Phase...